Shopping Cart
- Remove All
- Your shopping cart is currently empty
Tapotoclax (AMG-176) is an orally active MCL1 inhibitor for the study of myeloid leukemia.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $593 | In Stock | |
5 mg | $1,730 | In Stock | |
10 mg | $2,330 | In Stock | |
25 mg | $3,470 | In Stock | |
50 mg | $4,680 | In Stock |
Description | Tapotoclax (AMG-176) is an orally active MCL1 inhibitor for the study of myeloid leukemia. |
Targets&IC50 | MCL1:0.13 nM (Ki) |
In vitro | Tapotoclax is a potent inhibitor (Ki=0.13 nM) of the inducible myeloid leukemia cell differentiation protein MCL-1, with potential pro-apoptotic and anti-tumor activity. Upon administration, Tapotoclax binds to MCL-1, thereby inhibiting its function. This process prevents the formation of a complex between MCL-1 and Bcl-2-like protein 11 (BCL2L11; BIM) and further triggers apoptosis in tumor cells. [2] |
Alias | AMG-176, AMG176 |
Molecular Weight | 613.21 |
Formula | C33H41ClN2O5S |
Cas No. | 1883727-34-1 |
Smiles | C[C@H]1C/C=C/[C@@H]([C@@H]2CC[C@H]2CN3C[C@@]4(CCCC5=C4C=CC(=C5)Cl)COC6=C3C=C(C=C6)C(=O)NS(=O)(=O)[C@@H]1C)OC |
Relative Density. | 1.32 g/cm3 (Predicted) |
Storage | keep away from moisture,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 50 mg/mL (81.54 mM), Sonication is recommended | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.